Is XONE or JNJ a better dividend investment in 2026?

XONE currently yields 4.20% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: XONE offers higher current income.

What is the dividend yield difference between XONE and JNJ?

XONE has a forward dividend yield of 4.20% ($2.08/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 0.84 percentage points.

Home › Compare › XONE vs JNJ

XONE vs JNJ: Dividend Comparison 2026

XONE yields 4.20% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 XONE wins by $6.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

XONE

● Live price

4.20%

Share price

$49.52

Annual div

$2.08

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.3K

Annual income

$550.25

Full XONE calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — XONE vs JNJ

📍 XONE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	XONE	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, XONE + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

XONE pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XONE

Annual income on $10K today (after 15% tax)

$357.19/yr

After 10yr DRIP, annual income (after tax)

$467.71/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $235.90/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XONE + JNJ for your $10,000?

XONE: 50%JNJ: 50%

100% JNJ50/50100% XONE

Portfolio after 10yr

$23.2K

Annual income

$689.02/yr

Blended yield

2.97%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

XONE

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Altman Z

19.1

Piotroski

4/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XONE buys

JNJ buys

No recent congressional trades found for XONE or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricXONEJNJ

Forward yield	4.20% ✓	3.36%
Annual dividend / share	$2.08	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$26.3K ✓	$20.0K
Annual income after 10y	$550.25	$827.78 ✓
Total dividends collected	$4.9K	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy

Year-by-year: XONE vs JNJ ($10,000, DRIP)

Year	XONE Portfolio	XONE Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,120	$420.23	$10,676	$355.77	+$444.00 → XONE
2	$12,335	$436.73	$11,407	$389.39	+$928.00 → XONE
3	$13,652	$452.76	$12,198	$426.53	+$1.5K → XONE
4	$15,076	$468.29	$13,056	$467.62	+$2.0K → XONE
5	$16,614	$483.30	$13,987	$513.12	+$2.6K → XONE
6	$18,275	$497.78	$14,998	$563.56	+$3.3K → XONE
7	$20,066	$511.72	$16,098	$619.52	+$4.0K → XONE
8	$21,996	$525.11	$17,295	$681.69	+$4.7K → XONE
9	$24,073	$537.96	$18,599	$750.82	+$5.5K → XONE
10	$26,309	$550.25	$20,022	$827.78	+$6.3K → XONE

XONE vs JNJ: Complete Analysis 2026

XONE — Stock

The investment seeks to track the investment results of the Bloomberg US Treasury 1 Year Duration Index composed of U.S. Treasury securities with a duration between 6 and 18 months. Under normal circumstances, the fund will invest at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in a portfolio of U.S. Treasury securities that collectively have an average duration of approximately 1 year, either directly or indirectly (e.g., through derivatives). It is non-diversified.

Full XONE Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this XONE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XONE vs SCHD XONE vs JEPI XONE vs O XONE vs KO XONE vs MAIN XONE vs ABBV XONE vs MRK XONE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.